Julie A. Moreno

3.5k total citations · 2 hit papers
51 papers, 2.5k citations indexed

About

Julie A. Moreno is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Julie A. Moreno has authored 51 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 29 papers in Neurology and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Julie A. Moreno's work include Neuroinflammation and Neurodegeneration Mechanisms (24 papers), Prion Diseases and Protein Misfolding (17 papers) and Alzheimer's disease research and treatments (8 papers). Julie A. Moreno is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (24 papers), Prion Diseases and Protein Misfolding (17 papers) and Alzheimer's disease research and treatments (8 papers). Julie A. Moreno collaborates with scholars based in United States, United Kingdom and Mexico. Julie A. Moreno's co-authors include Giovanna R. Mallucci, Nicholas Verity, Helois Radford, Mark Halliday, David A. Barrett, Anne E. Willis, Catharine A. Ortori, Colin Molloy, Ronald B. Tjalkens and Peter M. Fischer and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Julie A. Moreno

44 papers receiving 2.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sustained translational repression by eIF2α-P mediates prion neurodegeneration

2012 489 citations Julie A. Moreno, Helois Radford et al. Nature profile →
Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice

2013 453 citations Julie A. Moreno, Colin Molloy et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Julie A. Moreno	1.4k	931	573	476	442	51	2.5k
Denis Ottolini	1.5k 1.1×	411 0.4×	491 0.9×	769 1.6×	162 0.4×	24	2.4k
Bingren Hu	1.4k 1.0×	478 0.5×	330 0.6×	772 1.6×	422 1.0×	51	2.5k
Daniele Bano	1.8k 1.3×	369 0.4×	469 0.8×	879 1.8×	366 0.8×	64	2.9k
Donald J. DeGracia	1.6k 1.2×	956 1.0×	461 0.8×	522 1.1×	385 0.9×	62	2.8k
Ruben K. Dagda	2.0k 1.5×	314 0.3×	587 1.0×	531 1.1×	212 0.5×	64	3.3k
Sı́lvio M. Zanata	1.7k 1.2×	257 0.3×	413 0.7×	454 1.0×	806 1.8×	67	3.0k
Vassiliki Nikoletopoulou	1.2k 0.9×	261 0.3×	316 0.6×	451 0.9×	202 0.5×	31	2.7k
Takayuki Manabe	1.3k 0.9×	821 0.9×	353 0.6×	323 0.7×	165 0.4×	76	2.5k
Xiulian Sun	1.4k 1.0×	230 0.2×	1.2k 2.0×	305 0.6×	257 0.6×	71	2.8k
Anthony K. F. Liou	1.1k 0.8×	246 0.3×	245 0.4×	361 0.8×	603 1.4×	27	2.3k

Countries citing papers authored by Julie A. Moreno

Since Specialization

Citations

This map shows the geographic impact of Julie A. Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. Moreno more than expected).

Fields of papers citing papers by Julie A. Moreno

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. Moreno. The network helps show where Julie A. Moreno may publish in the future.

Co-authorship network of co-authors of Julie A. Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. Moreno. A scholar is included among the top collaborators of Julie A. Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. Moreno. Julie A. Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McGrath, Stephanie, Matthew D. Dunbar, Evan L. MacLean, et al.. (2025). The companion dog as a translational model for Alzheimer's disease: Development of a longitudinal research platform and post mortem protocols. Alzheimer s & Dementia. 21(9). e70630–e70630.

Olby, Natasha J., Joseph A. Araujo, Margaret E. Gruen, et al.. (2025). The Canine Cognitive Dysfunction Syndrome Working Group guidelines for diagnosis and monitoring of canine cognitive dysfunction syndrome. Journal of the American Veterinary Medical Association. 264(4). 498–505.

Anton, Paige, Prashant Nagpal, Julie A. Moreno, et al.. (2025). Suppression of NF-κB/NLRP3 by nanoligomer therapy mitigates ethanol and advanced age-related neuroinflammation. Journal of Leukocyte Biology. 117(4). 1 indexed citations

McGrath, Stephanie, et al.. (2025). Plasma and cerebrospinal fluid biomarkers in aged dogs with cognitive decline. BMC Veterinary Research. 21(1). 617–617.

Popichak, Katriana A., Jifeng Bian, Eric M. Nicholson, et al.. (2025). Microglia-specific NF-κB signaling is a critical regulator of prion-induced glial inflammation and neuronal loss. PLoS Pathogens. 21(6). e1012582–e1012582. 1 indexed citations

Popichak, Katriana A., et al.. (2024). The Role of Glial Cells in Neurobiology and Prion Neuropathology. Cells. 13(10). 832–832. 2 indexed citations

Bray, Emily E., Stephanie McGrath, Gene E. Alexander, et al.. (2024). Characterizing dog cognitive aging using spontaneous problem-solving measures: development of a battery of tests from the Dog Aging Project. GeroScience. 47(1). 23–43. 1 indexed citations

Zambrano, Cristian A., Christopher E. Stamper, Adam D. Bohr, et al.. (2023). Effects of Mycobacterium vaccae NCTC 11659 and Lipopolysaccharide Challenge on Polarization of Murine BV-2 Microglial Cells. International Journal of Molecular Sciences. 25(1). 474–474. 1 indexed citations

Zabel, Mark D., et al.. (2023). Intranasally delivered mesenchymal stromal cells decrease glial inflammation early in prion disease. Frontiers in Neuroscience. 17. 1158408–1158408. 11 indexed citations

10.

Ackart, David F., et al.. (2023). Gliosis, misfolded protein aggregation, and neuronal loss in a guinea pig model of pulmonary tuberculosis. Frontiers in Neuroscience. 17. 1157652–1157652. 5 indexed citations

11.

McGrath, Stephanie, et al.. (2023). Activated gliosis, accumulation of amyloid β, and hyperphosphorylation of tau in aging canines with and without cognitive decline. Frontiers in Aging Neuroscience. 15. 1128521–1128521. 8 indexed citations

12.

Moreno, Julie A., et al.. (2022). Survey of risk factors and frequency of clinical signs observed with feline cognitive dysfunction syndrome. Journal of Feline Medicine and Surgery. 24(6). e131–e137. 3 indexed citations

13.

Telling, Glenn C., et al.. (2022). Tissue-specific biochemical differences between chronic wasting disease prions isolated from free-ranging white-tailed deer (Odocoileus virginianus). Journal of Biological Chemistry. 298(4). 101834–101834. 4 indexed citations

14.

Moreno, Julie A., et al.. (2022). Assessment of risk factors in dogs with presumptive advanced canine cognitive dysfunction. Frontiers in Veterinary Science. 9. 958488–958488. 9 indexed citations

15.

Moreno, Julie A. & Glenn C. Telling. (2017). Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases. Methods in molecular biology. 1658. 219–252. 21 indexed citations

16.

Moreno, Julie A. & Glenn C. Telling. (2017). Molecular Mechanisms of Chronic Wasting Disease Prion Propagation. Cold Spring Harbor Perspectives in Medicine. 8(6). a024448–a024448. 23 indexed citations

17.

Peretti, Diego, Amandine Bastide, Helois Radford, et al.. (2015). RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration. Nature. 518(7538). 236–239. 181 indexed citations

18.

Streifel, Karin M., Julie A. Moreno, William H. Hanneman, Marie E. Legare, & Ronald B. Tjalkens. (2011). Gene Deletion of nos2 Protects Against Manganese-Induced Neurological Dysfunction in Juvenile Mice. Toxicological Sciences. 126(1). 183–192. 26 indexed citations

19.

Carbone, David L., Katriana A. Popichak, Julie A. Moreno, Stephen Safe, & Ronald B. Tjalkens. (2008). Suppression of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Nitric-Oxide Synthase 2 Expression in Astrocytes by a Novel Diindolylmethane Analog Protects Striatal Neurons against Apoptosis. Molecular Pharmacology. 75(1). 35–43. 31 indexed citations

20.

Moreno, Julie A., Kelly A. Sullivan, David L. Carbone, William H. Hanneman, & Ronald B. Tjalkens. (2008). Manganese potentiates nuclear factor‐κB‐dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways. Journal of Neuroscience Research. 86(9). 2028–2038. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact